CZL80, a brain-penetrable caspase-1 inhibitor with an IC 50 of 0.01 μM, could be used in the study of febrile seizures and later enhanced epileptogenic susceptibility.
Products | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Signaling Pathways > Apoptosis | Products > Research Areas > Neurological Disease | Products > Signaling Pathways > Caspase
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.